EPT Disclosure


 

TIDMNPH 
 
RNS Number : 5033I 
Piper Jaffray Ltd 
12 March 2010 
 
                 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 
            WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS 
                  BUT NOT DEALING IN A CLIENT-SERVING CAPACITY 
                      (Rule 38.5(b) of the Takeover Code) 
 
 
1.         KEY INFORMATION 
 
+-----------------------+-----------------------------------+ 
| Name of exempt        | Piper Jaffray Ltd.                | 
| principal trader      |                                   | 
+-----------------------+-----------------------------------+ 
| Company dealt in      | Neuropharm Group plc              | 
+-----------------------+-----------------------------------+ 
| Class of relevant     | Ord 10p                           | 
| security to which the |                                   | 
| dealings being        |                                   | 
| disclosed             |                                   | 
| relate (Note 1)       |                                   | 
+-----------------------+-----------------------------------+ 
| Date of dealing       | 11 March 2010                     | 
+-----------------------+-----------------------------------+ 
 
 
2.         INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE 
 
(a)        Interests and short positions (following dealing) in the class of 
relevant security dealt in (Note 2) 
 
+-----------------------+----------------+---------------------------------------------------+ 
|                       |      Long      |                      Short                        | 
|                       |                |                                                   | 
+-----------------------+----------------+---------------------------------------------------+ 
|                       | Number         | Number                                            | 
|                       | (%)            | (%)                                               | 
+-----------------------+----------------+---------------------------------------------------+ 
| (1) Relevant          |                | 85,505                                    0.27%   | 
| securities            |                |                                                   | 
|                       |                |                                                   | 
+-----------------------+----------------+---------------------------------------------------+ 
| (2) Derivatives       |                |                                                   | 
| (other than options)  |                |                                                   | 
|                       |                |                                                   | 
+-----------------------+----------------+---------------------------------------------------+ 
| (3) Options and       |                |                                                   | 
| agreements to         |                |                                                   | 
| purchase/sell         |                |                                                   | 
|                       |                |                                                   | 
+-----------------------+----------------+---------------------------------------------------+ 
| Total                 |                | 85,505                                    0.27%   | 
|                       |                |                                                   | 
+-----------------------+----------------+---------------------------------------------------+ 
 
(b)        Interests and short positions in relevant securities of the company, 
other than the class dealt in (Note 2) 
 
+-----------------------+----------------+------------------+ 
|  Class of relevant    |      Long      |      Short       | 
|      security:        |                |                  | 
|                       |                |                  | 
+-----------------------+----------------+------------------+ 
|                       | Number         | Number           | 
|                       | (%)            | (%)              | 
+-----------------------+----------------+------------------+ 
| (1) Relevant          |                |                  | 
| securities            |                |                  | 
|                       |                |                  | 
+-----------------------+----------------+------------------+ 
| (2) Derivatives       |                |                  | 
| (other than options)  |                |                  | 
|                       |                |                  | 
+-----------------------+----------------+------------------+ 
| (3) Options and       |                |                  | 
| agreements to         |                |                  | 
| purchase/sell         |                |                  | 
|                       |                |                  | 
+-----------------------+----------------+------------------+ 
| Total                 |                |                  | 
|                       |                |                  | 
+-----------------------+----------------+------------------+ 
 
(c)        Rights to subscribe (Note 2) 
 
+-----------------------+-----------------------------------+ 
| Class of relevant     | Details                           | 
| security:             |                                   | 
|                       |                                   | 
+-----------------------+-----------------------------------+ 
|                       |                                   | 
+-----------------------+-----------------------------------+ 
 
3.         DEALINGS (Note 3) 
 
(a)        Purchases and sales 
 
+-------------------+------------------+--------------------+ 
| Purchase/sale     | Number of        | Price per unit     | 
|                   | securities       | (Note 4)           | 
+-------------------+------------------+--------------------+ 
| Buy               | 6,800            | 10.25p             | 
+-------------------+------------------+--------------------+ 
| Sell              | 11,000           | 11.50p             | 
+-------------------+------------------+--------------------+ 
 
 
(b)        Derivatives transactions (other than options) 
 
+----------+------------+------------------+----------------+ 
| Product  | Long/short | Number of        | Price per unit | 
| name,    | (Note 5)   | securities (Note | (Note 4)       | 
| e.g. CFD |            | 6)               |                | 
+----------+------------+------------------+----------------+ 
|          |            |                  |                | 
|          |            |                  |                | 
+----------+------------+------------------+----------------+ 
 
 
 
(c)        Options transactions in respect of existing securities 
(i)         Writing, selling, purchasing or varying 
 
+----------+-------------+------------+----------+-----------+--------+---------------+ 
| Product  | Writing,    | Number     | Exercise | Type,     | Expiry | Option        | 
| name,    | selling,    | of         | price    | e.g.      |        | money         | 
| e.g.     | purchasing, | securities |          | American, | date   | paid/received | 
| call     | varying     | to which   |          | European  |        | per unit      | 
| option   | etc.        | the option |          | etc.      |        | (Note 4)      | 
|          |             | relates    |          |           |        |               | 
|          |             | (Note 6)   |          |           |        |               | 
+----------+-------------+------------+----------+-----------+--------+---------------+ 
|          |             |            |          |           |        |               | 
+----------+-------------+------------+----------+-----------+--------+---------------+ 
 
 
(ii)        Exercising 
 
+-------------------+------------------+--------------------+ 
| Product name,     | Number of        | Exercise price per | 
| e.g. call option  | securities       | unit (Note 4)      | 
|                   |                  |                    | 
+-------------------+------------------+--------------------+ 
|                   |                  |                    | 
|                   |                  |                    | 
+-------------------+------------------+--------------------+ 
 
(d)        Other dealings (including new securities) (Note 3) 
 
+-------------------+------------------+--------------------+ 
| Nature of         | Details          | Price per unit (if | 
| transaction (Note |                  | applicable) (Note  | 
| 7)                |                  | 4)                 | 
|                   |                  |                    | 
+-------------------+------------------+--------------------+ 
|                   |                  |                    | 
|                   |                  |                    | 
+-------------------+------------------+--------------------+ 
 
 
4.         OTHER INFORMATION 
 
Agreements, arrangements or understandings relating to options or derivatives 
 
 
+-----------------------------------------------------------+ 
| Full details of any agreement, arrangement or             | 
| understanding between the person disclosing and any other | 
| person relating to the voting rights of any relevant      | 
| securities under any option referred to on this form or   | 
| relating to the voting rights or future acquisition or    | 
| disposal of any relevant securities to which any          | 
| derivative referred to on this form is referenced.  If    | 
| none, this should be stated.                              | 
+-----------------------------------------------------------+ 
|                                                           | 
|                                                           | 
|                                                           | 
+-----------------------------------------------------------+ 
 
 
Is a Supplemental Form 38.5(b) attached? (Note 8) NO 
 
 
+---------------------------------+-------------------------+ 
| Date of disclosure              | 12 March 2010           | 
+---------------------------------+-------------------------+ 
| Contact name                    | Norman Gould            | 
+---------------------------------+-------------------------+ 
| Telephone number                | 020 3142 8780           | 
+---------------------------------+-------------------------+ 
| Name of offeree/offeror with    | Neuropharm Group plc    | 
| which connected                 |                         | 
+---------------------------------+-------------------------+ 
| Nature of connection (Note 9)   | Adviser and broker      | 
+---------------------------------+-------------------------+ 
 
 
Notes 
 
The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at 
www.thetakeoverpanel.org.uk 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 EMMUUVRRRWAOAAR
Neuropharm (LSE:NPH)
過去株価チャート
から 11 2024 まで 12 2024